US judge sets structure for hearing in antitrust case against Takeda over Amitiza
MLex Summary: A US judge has issued an order laying out how a hearing in which Takeda Pharmaceuticals and end-payor plaintiffs will present evidence and arguments over possible adjustments to damages...To view the full article, register now.
Already a subscriber? Click here to view full article